News (ZH) - LGC, an international leader in the life sciences tools sector, is playing an active role in the global response to COVID-19
News (ZH) - Offers expanded genome coverage to include S gene region
News (ZH) - Solutions address critical need for clinical laboratories to be able to report antibody testing results with confidence
News (ZH) - Aims to refine testing approaches, stratify treatment options, determine isolation requirements and speed up measurement
News (ZH) - Panel demonstrates a range of SARS-CoV-2 antibody reactivity
News (ZH) - Research programme brings together experts who are highly experienced in evaluating diagnostic tests and generating robust evidence required for a test to be used in the NHS
News (ZH) - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma
News (ZH) - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features
News (ZH) - M4R will run until the end of 2020 and will enable businesses to have access to the world-leading chemical and bio-measurement expertise and capabilities at the NML.
News (ZH) - First commercially cvailable SARS-CoV-2 antibody test in UK compatible with Neoteryx’s Mitra® Microsampling Device for at-home blood collection